Explicit solutions for a class indirect pharmacodynamic response models

被引:4
作者
Jordan, P [1 ]
Gieschke, R [1 ]
机构
[1] F Hoffmann La Roche Ltd, Pharma Dev, Clin Sci, PDMB, CH-4070 Basel, Switzerland
关键词
indirect response model; explicit solution; hypergeometric function F-2(1); NONMEM;
D O I
10.1016/j.cmpb.2004.02.002
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Explicit solutions for four, ordinary differential equation (ODE)-based, types of indirect response models are presented. These response models were introduced by Dayneka et aL in 1993 [J. Pharmacokinet. Biopharm. 21 (1993) 457] to describe pharmacodynamic responses utilizing inhibitory or stimulatory Em,x type functions. The explicit solutions are expressed in terms of hypergeometric F-2(1) functions and their analytical continuations. A practical application is demonstrated for modeling the kinetics of drug action for ibandronate, a potent bisphosphonate that suppresses bone turnover resulting in a reduction in the markers of bone turnover. Ten times shorter model evaluation times, with the explicit solution compared with the differential equation implementation, may enhance situations where a large number of model evaluations are needed, such as clinical trial simulations and parameter estimation. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:91 / 97
页数:7
相关论文
共 12 条
[1]  
Abramowitz M., 1968, APPL MATH SERIES
[2]  
[Anonymous], PHARMACOKINETICS PHA
[3]  
ARFKEN GB, 1971, MATH METHS PHYS
[4]  
BOEKMANN AJ, 1994, INTRO GUIDE NONMEM P
[5]   COMPARISON OF 4 BASIC MODELS OF INDIRECT PHARMACODYNAMIC RESPONSES [J].
DAYNEKA, NL ;
GARG, V ;
JUSKO, WJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1993, 21 (04) :457-478
[6]  
GIESCHKE R, 2001, PAGE 10 M BAS SWITZ
[7]   UNDERSTANDING THE DOSE-EFFECT RELATIONSHIP - CLINICAL-APPLICATION OF PHARMACOKINETIC-PHARMACODYNAMIC MODELS [J].
HOLFORD, NHG ;
SHEINER, LB .
CLINICAL PHARMACOKINETICS, 1981, 6 (06) :429-453
[8]  
JACQMIN P, 2002, P 4 INT S MEAS KIN I
[9]  
JACQMIN P, 2001, PAGE 10 M BAS SWITZ
[10]  
Kimko HC., 2003, Simulation for designing clinical trials: a pharmacokinetic-pharmacodynamic modeling perspective drugs and the pharmaceutical sciences